StockData
BBNXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Beta Bionics, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$16.84+0.49 (+3.00%)

Close on Oct 19, 2026

Market cap
$750.14M
P/E (TTM)
–
Dividend yield
–

SEC filings

25 of Beta Bionics's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Current report8-KSep 15, 2026Sep 17, 2026SEC EDGAR
Current report8-KSep 14, 2026Sep 15, 2026SEC EDGAR
Quarterly report10-QJun 30, 2026Jul 29, 2026SEC EDGAR
Current report8-KJul 29, 2026Jul 29, 2026SEC EDGAR
Current report8-KMay 21, 2026May 22, 2026SEC EDGAR
Current report8-KMay 21, 2026May 21, 2026SEC EDGAR
Quarterly report10-QMar 31, 2026Apr 21, 2026SEC EDGAR
Current report8-KApr 21, 2026Apr 21, 2026SEC EDGAR
Proxy statementDEF 14AMay 21, 2026Apr 10, 2026SEC EDGAR
Annual report10-KDec 31, 2025Feb 24, 2026SEC EDGAR
Current report8-KFeb 17, 2026Feb 17, 2026SEC EDGAR
Current report8-KJan 29, 2026Jan 30, 2026SEC EDGAR
Current report8-KJan 8, 2026Jan 8, 2026SEC EDGAR
Quarterly report10-QSep 30, 2025Oct 28, 2025SEC EDGAR
Current report8-KOct 28, 2025Oct 28, 2025SEC EDGAR
Current report8-KJul 29, 2025Jul 29, 2025SEC EDGAR
Quarterly report10-QJun 30, 2025Jul 29, 2025SEC EDGAR
Current report8-KJun 22, 2025Jun 23, 2025SEC EDGAR
Current report8-KMay 6, 2025May 6, 2025SEC EDGAR
Quarterly report10-QMar 31, 2025May 6, 2025SEC EDGAR
Annual report, amended10-K/ADec 31, 2024Mar 28, 2025SEC EDGAR
Current report8-KMar 26, 2025Mar 27, 2025SEC EDGAR
Current report8-KMar 25, 2025Mar 25, 2025SEC EDGAR
Annual report10-KDec 31, 2024Mar 25, 2025SEC EDGAR
Current report8-KJan 31, 2025Jan 31, 2025SEC EDGAR